O
Oncobiologics
Cranbury, United States
Founded 2010
About
Biosimilar development with advanced formulation technology
Company Details
- Type
- commercial
- Employees
- 100-250
- Funding
- $250M
Key Products
- Biosimilars
- Formulation Platform
Biosimilar development with advanced formulation technology